FUT9-Driven Programming of Colon Cancer Cells towards a Stem Cell-Like State.

colon cancer drug resistance fucosylation glycosylation pluripotency stem cells

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
10 Sep 2020
Historique:
received: 09 06 2020
revised: 20 08 2020
accepted: 01 09 2020
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 16 9 2020
Statut: epublish

Résumé

Cancer stem cells (CSCs) are located in dedicated niches, where they remain inert to chemotherapeutic drugs and drive metastasis. Although plasticity in the CSC pool is well appreciated, the molecular mechanisms implicated in the regulation of cancer stemness are still elusive. Here, we define a fucosylation-dependent reprogramming of colon cancer cells towards a stem cell-like phenotype and function. De novo transcriptional activation of

Identifiants

pubmed: 32927726
pii: cancers12092580
doi: 10.3390/cancers12092580
pmc: PMC7565653
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union (Marie-Curie European Training Network), GlyCoCan project
ID : 676421
Organisme : Cancer Center Amsterdam (CCA)
ID : 2003849
Organisme : European Research Council, Glycotreat project
ID : 339977
Organisme : Dutch Cancer Society (KWF)
ID : 2014-6779
Organisme : Dutch Cancer Society (KWF)
ID : 12420

Références

World J Stem Cells. 2015 Oct 26;7(9):1150-84
pubmed: 26516408
Front Oncol. 2020 Aug 18;10:1622
pubmed: 33014816
Neoplasia. 2018 Aug;20(8):813-825
pubmed: 30015157
Int J Mol Sci. 2013 Jul 26;14(8):15636-54
pubmed: 23896595
Cancer Res. 2016 Jul 1;76(13):3978-88
pubmed: 27216178
J Clin Oncol. 2000 Jan;18(1):136-47
pubmed: 10623704
Cancer Res. 2013 Apr 1;73(7):2368-78
pubmed: 23358684
Cell Stem Cell. 2019 Dec 5;25(6):737-753.e4
pubmed: 31708402
Nat Commun. 2019 Apr 16;10(1):1787
pubmed: 30992437
Cell Death Differ. 2018 Mar;25(3):616-633
pubmed: 29305587
Immunology. 2018 Mar;153(3):304-314
pubmed: 29150846
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
J Proteome Res. 2015 Sep 4;14(9):3823-34
pubmed: 26244810
Lancet. 2000 Mar 25;355(9209):1041-7
pubmed: 10744089
J Cell Physiol. 2020 Mar;235(3):2037-2048
pubmed: 31612481
Oncogene. 2019 Aug;38(32):6051-6064
pubmed: 31292489
Front Oncol. 2018 Aug 21;8:322
pubmed: 30186768
Cell Stem Cell. 2012 Apr 6;10(4):440-54
pubmed: 22482508
Mol Cell Biol. 2006 May;26(9):3565-81
pubmed: 16611997
PLoS Comput Biol. 2014 Jul 24;10(7):e1003731
pubmed: 25058159
FEBS Lett. 1999 Jun 11;452(3):237-42
pubmed: 10386598
J Biol Chem. 2018 May 11;293(19):7300-7314
pubmed: 29593094
J Gastrointest Oncol. 2015 Apr;6(2):185-200
pubmed: 25830038
J Biol Chem. 2015 Sep 4;290(36):21890-900
pubmed: 26198631
Nat Med. 2017 Oct 6;23(10):1124-1134
pubmed: 28985214
Oncotarget. 2017 Dec 22;9(70):33403-33415
pubmed: 30279970
Cell Stem Cell. 2009 May 8;4(5):440-52
pubmed: 19427293
J Immunol. 2013 Mar 1;190(5):2381-90
pubmed: 23345327
Lancet Oncol. 2017 Dec;18(12):e731-e741
pubmed: 29208439
Gastrointest Cancer Res. 2010 Nov;(Suppl 1):S16-23
pubmed: 21472043
Oncogene. 2020 Jan;39(2):278-292
pubmed: 31477842
Glycobiology. 2000 Aug;10(8):789-802
pubmed: 10929005
Gastroenterology. 2009 Jul;137(1):188-98, 198.e1-2
pubmed: 19361506
J Biol Chem. 2014 Nov 7;289(45):31534-49
pubmed: 25274627
Cell Stem Cell. 2019 Apr 4;24(4):637-653.e9
pubmed: 30951662
Nat Med. 2011 Mar;17(3):313-9
pubmed: 21386835
Neuro Oncol. 2016 Feb;18(2):227-35
pubmed: 26188016
Oncotarget. 2016 Sep 20;7(38):61183-61198
pubmed: 27533463
Glycobiology. 2019 Feb 1;29(2):137-150
pubmed: 30476078
J Cell Physiol. 2019 Feb 11;:
pubmed: 30741412
Adv Exp Med Biol. 2015;867:247-60
pubmed: 26530370
Int J Mol Sci. 2019 May 11;20(9):
pubmed: 31083525
Annu Rev Pathol. 2016 May 23;11:47-76
pubmed: 27193450
Front Immunol. 2020 Feb 25;11:305
pubmed: 32161592
World J Stem Cells. 2019 Dec 26;11(12):1065-1083
pubmed: 31875869
Front Immunol. 2018 May 28;9:1135
pubmed: 29892288
Front Oncol. 2018 Feb 23;8:39
pubmed: 29527514
Oncotarget. 2018 Feb 5;9(17):13488-13500
pubmed: 29568372
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
J Clin Oncol. 2009 Aug 1;27(22):3671-6
pubmed: 19564531
Nat Cell Biol. 2018 Oct;20(10):1193-1202
pubmed: 30177776
Cell Rep. 2017 Dec 5;21(10):2813-2828
pubmed: 29212028
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Mol Syst Biol. 2017 Dec 1;13(12):956
pubmed: 29196508
Nature. 2017 Sep 28;549(7673):538-542
pubmed: 28959962
Mol Cell Proteomics. 2016 Jan;15(1):124-40
pubmed: 26537799
Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):361-375
pubmed: 30886395
J Oncol. 2019 May 2;2019:8752862
pubmed: 31186640
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9020-9029
pubmed: 30996127
Trends Cell Biol. 2017 Dec;27(12):895-905
pubmed: 28890254
Nucleic Acids Res. 2009 Jan;37(Database issue):D674-9
pubmed: 18832364
Nat Genet. 2017 May;49(5):708-718
pubmed: 28319088
Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797
pubmed: 29229854
Glycoconj J. 2017 Aug;34(4):441-452
pubmed: 28624993
Curr Cancer Drug Targets. 2019;19(7):515-524
pubmed: 30338738
Clin Proteomics. 2018 Mar 2;15:9
pubmed: 29507546
Ann Surg Oncol. 2013 Dec;20(13):4289-97
pubmed: 23955585
Biochim Biophys Acta. 2012 Dec;1820(12):2007-19
pubmed: 23000574
Nat Rev Cancer. 2015 Sep;15(9):540-55
pubmed: 26289314
Cancers (Basel). 2019 Jun 21;11(6):
pubmed: 31234336
Oncotarget. 2014 Jun 15;5(11):3673-84
pubmed: 25003232
Nat Genet. 2008 May;40(5):499-507
pubmed: 18443585
Exp Mol Med. 2018 Aug 14;50(8):101
pubmed: 30111797
Nat Commun. 2018 Mar 9;9(1):1024
pubmed: 29523784
Carcinogenesis. 2019 Jan 30;:
pubmed: 30715269
Theor Appl Genet. 2009 Mar;118(5):849-63
pubmed: 19130034
Oncotarget. 2017 Nov 3;9(1):1380-1402
pubmed: 29416702
Oncotarget. 2017 Jun 9;8(33):54775-54787
pubmed: 28903381
Stem Cells Int. 2019 Jan 13;2019:3904645
pubmed: 30733805
Arch Biochem Biophys. 1996 Nov 1;335(1):109-17
pubmed: 8914840
Nat Protoc. 2013 Nov;8(11):2281-2308
pubmed: 24157548
Cancer Lett. 2019 May 28;450:1-13
pubmed: 30776481
Front Oncol. 2019 Nov 20;9:1230
pubmed: 31824839
Sci Rep. 2018 Dec 5;8(1):17639
pubmed: 30518951
Int J Cancer. 2019 May 1;144(9):2290-2302
pubmed: 30578646
Gastroenterol Rep (Oxf). 2019 Nov 25;8(1):11-24
pubmed: 32104582
Cancer Manag Res. 2018 Dec 31;11:369-378
pubmed: 30643462
Glycobiology. 2017 Jan;27(1):3-49
pubmed: 27558841

Auteurs

Athanasios Blanas (A)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Anouk Zaal (A)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Irene van der Haar Àvila (I)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Maxime Kempers (M)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Laura Kruijssen (L)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Mike de Kok (M)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Marko A Popovic (MA)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Joost C van der Horst (JC)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Sandra J van Vliet (S)

Department of Molecular Cell Biology and Immunology, Amsterdam Infection & Immunity Institute, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam UMC, 1081 HZ Amsterdam, The Netherlands.

Classifications MeSH